United States · Funded startup
5 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$88Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Source recorded
No investor was named in the report.
Reported by sec.govSEC filing: $30M sold, first sale Oct 2013
Reported by finsmes.comSEC filing: $10M sold, first sale Dec 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MPM CapitalAvalon Ventures
Cultivian Ventures
Kansas Bioscience AuthorityFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
This firm lists Aratana Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Aratana Therapeutics's investors include MPM Capital, Avalon Ventures, Cultivian Ventures and Kansas Bioscience Authority.
Aratana Therapeutics has raised $88M across 5 rounds since 2011.
Aratana Therapeutics's most recent round was an Undisclosed round of $12M in Mar 2018.
Aratana Therapeutics's largest round on record is $30M (Venture), in Oct 2013.
Aratana Therapeutics's first round on record, in Jan 2011, was backed by MPM Capital, Avalon Ventures and Kansas Bioscience Authority.
Aratana Therapeutics's latest named round is an Undisclosed round, in Mar 2018.
Aratana Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
